The CANCER-ID consortium is looking forward to its 3rd Task Leader Meeting on October 4. The this year´s autum meeting will be hosted by the CANCER-ID partner ORION in Espoo, Finland. The main focus will be the transition from the pre-evaluation phase of the project to the clinical phase.